BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12834179)

  • 1. Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
    Takahashi H; Muto S; Nakazawa E; Yanagiba S; Masunaga Y; Miyata Y; Tamba K; Kusano E; Matsuo M; Matsuo T; Asano Y
    Clin Nephrol; 2003 Jun; 59(6):458-62. PubMed ID: 12834179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
    Matsuo T; Matsuo M; Ouga-Maruyama S
    Thromb Haemost; 2001 Oct; 86(4):1115-6. PubMed ID: 11686333
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis.
    Matsuo T; Yamada T; Chikahira Y; Kadowaki S
    Blut; 1989 Oct; 59(4):393-5. PubMed ID: 2790222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic complications in three hemodialysis patients with heparin-induced thrombocytopenia type I.
    Suzuki S; Sakamoto S; Matsuo M; Shimano C; Kuroda T; Matsuo T
    Clin Appl Thromb Hemost; 2004 Jan; 10(1):81-4. PubMed ID: 14979412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
    Matsuo T; Wanaka K
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):459-64. PubMed ID: 18160571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia (HIT) in patients on hemodialysis: an update.
    Szromba C
    Nephrol Nurs J; 2010; 37(2):185-7. PubMed ID: 20462079
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.
    Almeida JI; Coats R; Liem TK; Silver D
    J Vasc Surg; 1998 Feb; 27(2):309-14; discussion 315-6. PubMed ID: 9510285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia with pseudo-pulmonary embolism in a patient who was newly introduced to hemodialysis treatment].
    Watarai R; Aoyama T; Kamata M; Miyazawa M; Ogawa M; Okina C; Murano J; Tanaka K; Aoyama M; Nakano M; Sano T; Kamata K
    Nihon Jinzo Gakkai Shi; 2015; 57(7):1248-52. PubMed ID: 26665617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report.
    Furuto Y; Kawamura M; Yamashita J; Yoshikawa T; Namikawa A; Isshiki R; Takahashi H; Shibuya Y
    BMC Nephrol; 2021 Jun; 22(1):220. PubMed ID: 34126959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafamostat mesilate for anticoagulation in continuous renal replacement therapy.
    Hwang SD; Hyun YK; Moon SJ; Lee SC; Yoon SY
    Int J Artif Organs; 2013 Mar; 36(3):208-16. PubMed ID: 23404639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.
    Lim JH; Kang KP; Lee S; Park SK; Kim W
    Hemodial Int; 2017 Apr; 21(2):E30-E33. PubMed ID: 27734602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an anticoagulant (heparin versus nafamostat mesilate) on the extrinsic coagulation pathway in chronic hemodialysis.
    Matsuo T; Matsuo M; Kario K; Koide M
    Blood Coagul Fibrinolysis; 1998 Jun; 9(4):391-3. PubMed ID: 9690813
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
    Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
    Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia--a big deal? It should be!
    Jamani N; Ouwendyk M
    CANNT J; 2000; 10(2):30-5, 39-44; quiz 36-8. PubMed ID: 15712466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
    Moroi K; Shiomi Y; Kumano H; Ishimura N; Nishiwada M
    Masui; 1997 Aug; 46(8):1085-9. PubMed ID: 9283165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Selleng S; Greinacher A
    Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.